Barclays PLC X4 Pharmaceuticals, Inc Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in X4 Pharmaceuticals, Inc stock. As of the latest transaction made, Barclays PLC holds 277,682 shares of XFOR stock, worth $94,411. This represents 0.0% of its overall portfolio holdings.

Number of Shares

277,682

Previous 93,821 195.97%

Holding current value

$94,411

Previous $54,000 242.59%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$0.54 - $0.86 $99,284 - $158,120	183,861 Added 195.97%	277,682 $185,000
Q2 2024 Aug 14, 2024	SELL	$0.58 - $1.47 $205,834 - $521,683	-354,887 Reduced 79.09%	93,821 $54,000
Q1 2024 May 15, 2024	SELL	$0.72 - $1.46 $58,242 - $118,103	-80,893 Reduced 15.27%	448,708 $623,000
Q4 2023 Feb 15, 2024	BUY	$0.61 - $0.99 $89,954 - $145,992	147,467 Added 38.59%	529,601 $443,000
Q3 2023 Nov 07, 2023	BUY	$1.03 - $2.02 $303,082 - $594,395	294,255 Added 334.84%	382,134 $417,000
Q2 2023 Aug 03, 2023	BUY	$0.82 - $2.49 $72,060 - $218,818	87,879 New	87,879 $170,000
Q2 2022 Aug 12, 2022	SELL	$0.88 - $1.91 $6,779 - $14,714	-7,704 Reduced 98.72%	100 $0
Q4 2021 Feb 14, 2022	SELL	$1.9 - $5.6 $3,980 - $11,732	-2,095 Reduced 21.16%	7,804 $18,000
Q3 2021 Nov 09, 2021	SELL	$4.53 - $6.45 $29,494 - $41,995	-6,511 Reduced 39.68%	9,899 $52,000
Q2 2021 Aug 13, 2021	SELL	$6.49 - $9.56 $31,379 - $46,222	-4,835 Reduced 22.76%	16,410 $107,000
Q1 2021 May 13, 2021	BUY	$6.63 - $10.28 $54,710 - $84,830	8,252 Added 63.51%	21,245 $183,000
Q4 2020 Feb 11, 2021	BUY	$5.41 - $7.4 $70,292 - $96,148	12,993 New	12,993 $83,000
Q3 2020 Nov 12, 2020	SELL	$6.09 - $9.15 $852 - $1,281	-140 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$7.98 - $10.44 $1,117 - $1,461	140 New	140 $1,000
Q1 2020 May 13, 2020	SELL	$6.03 - $11.01 $105,904 - $193,368	-17,563 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$9.93 - $14.33 $116,290 - $167,818	11,711 Added 200.12%	17,563 $188,000
Q3 2019 Nov 14, 2019	BUY	$11.06 - $15.75 $64,723 - $92,169	5,852 New	5,852 $74,000
Q2 2019 Aug 14, 2019	SELL	$12.57 - $21.67 $3,079 - $5,309	-245 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$15.19 - $22.98 $3,721 - $5,630	245 New	245 $4,000

Others Institutions Holding XFOR

# of Institutions

105

Shares Held

100M

Call Options Held

213K

Put Options Held

50.6K

View Full List

About X4 Pharmaceuticals, Inc

Ticker XFOR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,646,096
Market Cap $23.3M
Description
X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...

More about XFOR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account